"False"
Skip to content
printicon
Main menu hidden.
Published: 2024-12-06

New Cancer Fund millions for UMU research

NEWS The Swedish Cancer Society has decided to give approximately 30 million SEK in the autumn call to ten research projects at Umeå University.

Text: Ola Nilsson
  • Anna Arnqvist Björklund. Department of Medical Biochemistry and Biophysics, 1,8 Million SEK to the project: Helicobacter pylori - Molecular mechanisms that promote persistent infection which can cause damages to the host cell and development of gastric cancer

  • Martin Cohn, Department of Molecular Biology, 3 Million SEK to the project: Molecular understanding of the childhood cancer syndrome Fanconi Anemia - potential for therapeutic opportunities.

  • Sofie Degerman, Department of Clinical Microbiology, 2,4 Million SEK to the project: DNA methylation as a tool to personalize the treatment of T-cell malignancies.

  • Sophia Harlid, Department of Diagnostics and Intervention, 2,4 Million SEK to the project: Environmental exposures during windows of susceptibility and implications for breast cancer risk and prevention.

  • Andreas Josefsson, Department of Diagnostics and Intervention, 3 Million SEK for the project: Development of novel treatment predictive methods for high-risk prostate cancer – markers for early and acquired resistance mechanisms in clinical samples.

  • Beatrice Melin, Department of Diagnostics and Intervention, 6 Million SEK for the project: Understanding glioma etiology - a complex disease requires diverse approaches to therapy.

  • Tufve Nyholm, Department of Diagnostics and Intervention, 3 Million SEK for the project: Understanding the characteristics of prostate cancer through imaging - paving the way for intensified radiotherapy.

  • Silvia Remeseiro, UCMM, 3 Million SEK for the project: New targets to blockneuron-to-glioma synapses in glioblastoma: disrupting malignant gene regulatory networks.

  • Pernilla Wikström, Department of Medical Biosciences, 3,75 Million SEK for the project: Metastasis heterogeneities provide possibilities for personalized therapy of patients with aggressive prostate cancer.

  • Sara Wilson, Department of Medical and Translational Biology, 3 Million SEK for the project: Identifying druggable targets of nerve-tumor interactions.

    In total, The Swedish Cancer Society distribute 887 Million SEK to approximately 200 research projects all over Sweden.